ILUMIEN IOptimizing Stent Parameters with Optical Coherence Tomography (OCT) in Patients Undergoing Fractional Flow Reserve (FFR) and Percutaneous Coronary Intervention
This study aims to observe how often Optical Coherence Tomography (OCT) guidance is used during stenting procedures in patients undergoing Fractional Flow Reserve (FFR) and Percutaneous Coronary Intervention, and how this relates to patient outcomes both in-hospital and up to 12 months later.
Device Data
Collected from today forward - ProspectiveAmino Acid Metabolism, Inborn Errors+19
+ Arterial Occlusive Diseases
+ Arteriosclerosis
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Summary
Study start date: December 11, 2012
Actual date on which the first participant was enrolled.Optical coherence tomography (OCT) is an imaging modality that uses near-infrared light to produce high resolution, real-time images that are clearer and more quickly produced than those produced by intravascular ultrasound (IVUS). OCT imaging is performed utilizing an imaging catheter with a single optical fiber core that both emits light and records its reflection while simultaneously rotating 360° during continuous pullback within the coronary artery. Fractional Flow Reserve (FFR) is a pressure-derived, lesion-specific, physiological index determining the hemodynamic severity of intracoronary lesions. FFR is measured by placing a pressure guidewire across the lesion of interest and pharmacologically inducing hyperemia. The ratio of distal to proximal pressure allows the physician to physiologically determine if the narrowing is the cause of ischemia. the goal of this study is to define new parameters for stent optimization, benefitting from the unique Fourier-domain (FD-OCT) capabilities. This stage I study will identify the parameters which will be prospectively tested in a second stage II protocol. In hospital, 30 day, and 12 month outcomes data will be correlated with OCT baseline findings in order to identify optimal stent implant parameters.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.418 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 36 locations
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, United StatesOpen University Hospital - Univ. of Alabama at Birmingham (UAB) in Google MapsScripps Clinic, Green Hospital
La Jolla, United StatesFlorida Hospital Orlando
Orlando, United StatesEmory University Hospital
Atlanta, United States